GlycoMimetics to Report Fourth Quarter and Year-End 2020 Financial Results on March 2
February 23 2021 - 4:30PM
Business Wire
GlycoMimetics, Inc. (Nasdaq: GLYC), today announces that it will
host a conference call and webcast to report fourth quarter and
year-end 2020 financial results on Tuesday, March 2, 2021, at 8:30
a.m. ET.
The dial-in number for the conference call is (844) 413-7154 for
domestic participants or (216) 562-0466 for international
participants, with participant code 1034166. Participants are
encouraged to connect 15 minutes in advance of the call to ensure
that all callers are able to connect.
A webcast replay will be available via the “Investors” tab on
the GlycoMimetics website for 30 days following the call. A dial-in
phone replay will be available for 24 hours after the close of the
call by dialing (855) 859-2056 for domestic participants and (404)
537-3406 for international participants, participant code
1034166.
About GlycoMimetics, Inc.
GlycoMimetics is a biotechnology company with a focus in
hematology-oncology and a pipeline of novel glycomimetic drugs, all
designed to address unmet medical needs resulting from diseases in
which carbohydrate biology plays a key role. GlycoMimetics' drug
candidate, uproleselan, an E-selectin antagonist, was evaluated in
a Phase 1/2 clinical trial as a potential treatment for AML and is
being evaluated across a range of patient populations including in
a Company-sponsored Phase 3 trial in relapsed/refractory AML under
Breakthrough Therapy Designation. Rivipansel, a pan-selectin
antagonist, is being explored for use in treatment of acute VOC in
sickle cell disease. GlycoMimetics has also completed a Phase 1
clinical trial with another wholly-owned drug candidate, GMI-1359,
a combined CXCR4 and E-selectin antagonist. GlycoMimetics is
located in Rockville, MD in the BioHealth Capital Region. Learn
more at www.glycomimetics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210223006084/en/
Investors: Shari Annes Phone: 650-888-0902 Email:
sannes@annesassociates.com Media: Jamie Lacey-Moreira Phone:
410-299-3310 Email: jamielacey@presscommpr.com
GlycoMimetics (NASDAQ:GLYC)
Historical Stock Chart
From Mar 2024 to Apr 2024
GlycoMimetics (NASDAQ:GLYC)
Historical Stock Chart
From Apr 2023 to Apr 2024
